UPDATE 1-Takeda, Lilly lose bid to overturn $9 bln award for hiding cancer risk

* Takeda shares muted, up 0.4 pct (Adds Takeda comment, Actos study result, share price, other details)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.